Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-002033
Filing Date
2025-06-06
Accepted
2025-06-06 16:27:20
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3639
  Complete submission text file 0000905148-25-002033.txt   5026
Mailing Address OLE MAALOES VEH 3 COPENHAGEN G7 2200
Business Address OLE MAALOES VEH 3 COPENHAGEN G7 2200 4570702980
IO Biotech, Inc. (Issuer) CIK: 0001865494 (see all company filings)

EIN.: 870909276 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUTRO BIOPHARMA, INC. 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address
Hunter Heidi (Reporting) CIK: 0001891841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41008 | Film No.: 251031110